,drug_id,Name,Synonyms,Targets,Target pathway,PubCHEM,Sample Size,Count,ID,Structure
0,1242,(5Z)-7-Oxozeaenol,"5Z-7-Oxozeaenol, LL-Z1640-2",TAK1,"Other, kinases",9863776,945,266,9863776,COc1cc(O)c2c(c1)C=CCC(O)C(O)C(=O)C=CCC(C)OC2=O
1,179,5-Fluorouracil,5-FU,Antimetabolite (DNA & RNA),Other,3385,968,266,3385,O=c1[nH]cc(F)c(=O)[nH]1
2,86,A-443654,KIN001-139,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,10172943,425,266,10172943,Cc1[nH]nc2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12
3,55,A-770041,KIN001-111,"LCK, FYN","Other, kinases",9549184,426,266,9549184,COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C
4,1001,AICA Ribonucleotide,"AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide",AMPK agonist,Metabolism,65110,872,266,65110,NC(=O)c1ncn(C2OC(COP(=O)(O)O)C(O)C2O)c1N
5,171,AKT inhibitor VIII,Akti-1/2,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,10196499,934,266,10196499,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1
6,228,AKT inhibitor VIII,"Akti-1/2, KIN001-102","AKT1, AKT2, AKT3",PI3K/MTOR signaling,10196499,979,266,10196499,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1
7,272,AR-42,"HDAC-42, AR 42, AR42",HDAC1,Chromatin histone acetylation,6918848,965,266,6918848,CC(C)C(C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1
8,207,AS601245,,"JNK1, JNK2, JNK2",JNK and p38 signaling,10109823,925,266,10109823,N#CC(c1ccnc(NCCc2cccnc2)n1)c1nc2ccccc2s1
9,224,AS605240,"KIN001-173, AS-605240",PI3Kgamma,PI3K/MTOR signaling,5289247,975,266,5289247,O=C1NC(=O)C(=Cc2ccc3nccnc3c2)S1
10,219,AT-7519,AT7519,"CDK1, CDK2, CDK4, CDK6, CDK9",Cell cycle,11338033,976,266,11338033,O=C(NC1CCNCC1)c1[nH]ncc1NC(=O)c1c(Cl)cccc1Cl
11,29,AZ628,"AZ-628, AZ 628",BRAF,ERK MAPK signaling,11676786,428,266,11676786,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1
12,156,AZD6482,"AZD 6482, AZD-6482, AK-55409",PI3Kbeta,PI3K/MTOR signaling,44137675,933,266,44137675,Cc1cc(C(C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1
13,1066,AZD6482,"AZD 6482, AZD-6482, AK-55409",PI3Kbeta,PI3K/MTOR signaling,44137675,931,266,44137675,Cc1cc(C(C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1
14,1022,AZD7762,"AZD-7762, AZD 7762","CHEK1, CHEK2",Cell cycle,11152667,881,266,11152667,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)NC1CCCNC1
15,1059,AZD8055,AZD-8055,"MTORC1, MTORC2",PI3K/MTOR signaling,25262965,870,266,25262965,COc1ccc(-c2ccc3c(N4CCOCC4C)nc(N4CCOCC4C)nc3n2)cc1CO
16,1032,Afatinib,"BIBW2992, Tovok, Gilotrif","ERBB2, EGFR",EGFR signaling,10184653,881,266,10184653,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1
17,1377,Afatinib,"BIBW2992, Tovok, Gilotrif","ERBB2, EGFR",EGFR signaling,10184653,944,266,10184653,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC1CCOC1
18,281,Alectinib,"CH5424802, CH 542802, Alecensa",ALK,RTK signaling,49806720,974,266,49806720,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O
19,293,Amuvatinib,"MP470, MP 470, MP-470","KIT, PDGFRA, FLT3","Other, kinases",11282283,971,266,11282283,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1
20,205,Avagacestat,"BMS-708163, BMS 708163","Amyloid beta20, Amyloid beta40",Other,46883536,977,266,46883536,NC(=O)C(CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1
21,1072,Avagacestat,"BMS-708163, BMS 708163","Amyloid beta20, Amyloid beta40",Other,46883536,957,266,46883536,NC(=O)C(CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1
22,1021,Axitinib,"AG-13736, Inlyta","PDGFR, KIT, VEGFR",RTK signaling,6450551,877,266,6450551,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1
23,178,BAY-61-3606,"Syk Inhibitor, BAY-613606",SYK,"Other, kinases",10200390,925,266,10200390,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC
24,60,BI-2536,,"PLK1, PLK2, PLK3",Cell cycle,11364421,424,266,11364421,CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1
25,279,BIX02189,BIX 02189,"MEK5, ERK5",ERK MAPK signaling,46931012,975,266,46931012,CN(C)Cc1cccc(NC(=C2C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)c1
26,203,BMS-345541,"BMS345541, IKK Inhibitor 3","IKK1, IKK2","Other, kinases",9813758,980,266,9813758,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1
27,63,BMS-509744,"KIN001-127, ITK inhibitor",ITK,Other,20635522,426,266,20635522,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1
28,62,BMS-536924,BMS 536924,"IGF1R, IR",IGFR signaling,10390396,425,266,10390396,Cc1cc(N2CCOCC2)cc2c1NC(=C1C(=O)N=CC=C1NCC(O)c1cccc(Cl)c1)N2
29,1091,BMS-536924,BMS 536924,"IGF1R, IR",Unclassified,10390396,956,266,10390396,Cc1cc(N2CCOCC2)cc2c1NC(=C1C(=O)N=CC=C1NCC(O)c1cccc(Cl)c1)N2
30,184,BMS-754807,"BMS754807, BMS 754807","IGF1R, IR",IGFR signaling,24785538,924,266,24785538,CC1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)[nH]n2)c2cccn2n1
31,222,BX-912,,PDK1 (PDPK1),PI3K/MTOR signaling,11754511,978,266,11754511,O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1
32,1037,BX795,BX-795,"TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC",Other,10077147,878,266,10077147,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1
33,274,Belinostat,"PXD101, PXD-101",HDAC1,Chromatin histone acetylation,6918638,948,266,6918638,O=C(C=Cc1cccc(S(=O)(=O)Nc2ccccc2)c1)NO
34,186,Bexarotene,"LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum",Retinioic X receptor (RXR) agonist,Other,82146,917,266,82146,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C
35,150,Bicalutamide,"ICI-176334, Casodex, Cosudex, ICI 176334",AR,Hormone-related,2375,927,266,2375,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
36,1502,Bicalutamide,"ICI-176334, Casodex, Cosudex, ICI 176334",AR,Hormone-related,2375,903,266,2375,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
37,190,Bleomycin,,dsDNA break induction,DNA replication,several,920,266,,
38,17,Cyclopamine,,SMO,Other,several,421,266,,
39,153,Midostaurin,"PKC412, benzoylstaurosporine, CGP-41251","PKC, PPK, FLT1, c-FGR, others",Other,several,938,266,,
40,1378,Bleomycin,,dsDNA break induction,DNA replication,5460769,965,266,5460769,Cc1c(N)nc(C(CC(N)=O)NCC(N)C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)C(C)O)C(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1cnc[nH]1
41,104,Bortezomib,"PS-341, LDP-341, Velcade",Proteasome,Protein stability and degradation,387447,426,266,387447,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
42,1019,Bosutinib,"SKI-606, Bosulif","SRC, ABL, TEC","Other, kinases",5328940,883,266,5328940,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
43,197,Bryostatin 1,Bryostatin,PKC,"Other, kinases",5280757,923,266,5280757,CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(C(C)O)OC(=O)CC(O)CC3CC(OC(C)=O)C(C)(C)C(O)(CC4CC(=CC(=O)OC)CC(C=CC(C)(C)C1(O)O2)O4)O3
44,276,CAY10603,,"HDAC1, HDAC6",Chromatin histone acetylation,24951314,968,266,24951314,CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1
45,1170,CCT-018159,"CCT018159, CCT 018159",HSP90,Protein stability and degradation,5327091,929,266,5327091,CCC1=CC(=C2NNC(C)=C2c2ccc3c(c2)OCCO3)C(=O)C=C1O
46,1067,CCT007093,,PPM1D,Other,2314623,952,266,2314623,O=C1C(=Cc2cccs2)CCC1=Cc1cccs1
47,54,CGP-082996,"CINK4, KIN001-021",CDK4,Cell cycle,24825971,425,266,24825971,CCNc1cc(NC2CCC(O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1
48,53,CGP-60474,"KIN001-019, CGP60474, CGP 60474","CDK1,CDK2,CDK5,CDK7,CDK9, PKC",Cell cycle,644215,425,266,644215,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1
49,154,CHIR-99021,"CT 99021, CHIR99021, CHIR 99021","GSK3A, GSK3B",WNT signaling,9956119,935,266,9956119,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1
50,1241,CHIR-99021,"CT 99021, CHIR99021, CHIR 99021","GSK3A, GSK3B",WNT signaling,9956119,944,266,9956119,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1
51,1015,CI-1040,"CI 1040, PD-18435, PD-184352, 212631-79-3","MEK1, MEK2",ERK MAPK signaling,6918454,871,266,6918454,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl
52,64,CMK,KIN001-128,RSK2,ERK MAPK signaling,16663089,425,266,16663089,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1
53,152,CP466722,"CP-466722, CP 466722, 1080622-86-1",ATM,Genome integrity,44551660,980,266,44551660,COc1cc2ncnc(-n3nc(-c4ccccn4)nc3N)c2cc1OC
54,255,CP724714,CP-724714,ERBB2,EGFR signaling,9874913,977,266,9874913,COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
55,273,CUDC-101,CUDC 101,"HDAC1-10, EGFR, ERBB2",Other,24756910,957,266,24756910,C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
56,300,CX-5461,"CX5461, CX 5461",RNA Polymerase 1,Other,25257557,971,266,25257557,Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1
57,249,Cabozantinib,"BMS-907351, XL-184, Cometriq","VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL","Other, kinases",25102847,975,266,25102847,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC
58,1114,Cetuximab,"Erbitux, IMC-C225, C225, IMC-225, L01XC06",EGFR,EGFR signaling,85668777,899,266,85668777,C=C1N(CCCCCC(=O)O)c2ccccc2C1(C)C
59,1005,Cisplatin,"cis-Diammineplatinum(II) dichloride, Platinol, CIS-DDP",DNA crosslinker,DNA replication,84691,882,266,84691,N.N.[Cl-].[Cl-].[Pt+2]
60,37,Crizotinib,"Xalkori, PF2341066, PF-2341066, PF 2341066","MET, ALK, ROS1",RTK signaling,11626560,433,266,11626560,CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl
61,1006,Cytarabine,"Ara-Cytidine, Arabinosyl Cytosine, U-19920",Antimetabolite,DNA replication,6253,878,266,6253,Nc1ccn(C2OC(CO)C(O)C2O)c(=O)n1
62,165,DMOG,Dimethyloxalylglcine,HIF-PH,Metabolism,560326,934,266,560326,COC(=O)CNC(=O)C(=O)OC
63,1373,Dabrafenib,"GSK2118436, Tafinlar",BRAF,ERK MAPK signaling,44462760,899,266,44462760,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1
64,200,Dacinostat,"NVP-LAQ824, LAQ824",HDAC1,Chromatin histone acetylation,6445533,929,266,6445533,O=C(C=Cc1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO
65,1057,Dactolisib,"NVP-BEZ235, BEZ235","PI3K (Class 1), MTORC1, MTORC2",PI3K/MTOR signaling,11977753,871,266,11977753,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21
66,1248,Daporinad,"APO866,  FK866, FK866",NAMPT,Metabolism,6914657,930,266,6914657,O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1
67,51,Dasatinib,"BMS-354825-03, BMS-354825, Sprycel","ABL, SRC, Ephrins, PDGFR, KIT",Other,3062316,422,266,3062316,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
68,1007,Docetaxel,"RP-56976, Taxotere",Microtubule stabiliser,Mitosis,148124,882,266,148124,CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c4ccccc4)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C
69,1042,Doramapimod,"BIRB-796, BIRB 796","p38, JNK2",JNK and p38 signaling,156422,867,266,156422,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1
70,133,Doxorubicin,"Doxil, Rubex, Adriamycin, Adriablastin, Doxorubicine",Anthracycline,DNA replication,31703,928,266,31703,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1
71,1069,EHT-1864,EHT 1864,"RAC1, RAC2, RAC3",Cytoskeleton,9938202,955,266,9938202,Cl.Cl.O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12
72,1031,Elesclomol,STA-4783,HSP90,Protein stability and degradation,300471,881,266,300471,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1
73,172,Embelin,"Emberine, Embelic acid",XIAP,Apoptosis regulation,3218,929,266,3218,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O
74,88,Entinostat,MS-275,"HDAC1, HDAC3",Chromatin histone acetylation,4261,427,266,4261,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1
75,229,Enzastaurin,LY317615,PKCB,"Other, kinases",176167,978,266,176167,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21
76,201,Epothilone B,"Patupilone, EpoB, EPO906, GNF-PF-193",Microtubule stabiliser,Mitosis,448013,928,266,448013,CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1
77,1,Erlotinib,"Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415",EGFR,EGFR signaling,176870,392,266,176870,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
78,134,Etoposide,"Etopophos, Vepesid, Eposin, VP-16",TOP2,DNA replication,36462,936,266,36462,COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O
79,173,FH535,,"PPARgamma, PPARdelta",WNT signaling,3463933,926,266,3463933,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl
80,231,FMK,KIN001-242,RSK,"Other, kinases",none,836,266,,
81,225,Genentech Cpd 10,,"AURKA, AURKB",Mitosis,none,980,266,,
82,1142,HG-5-113-01,,"LOK, LTK, TRCB, ABL(T315I)",Other,none,512,266,,
83,1143,HG-5-88-01,,"EGFR, ADCK4","Other, kinases",none,512,266,,
84,164,JQ12,,"HDAC1, HDAC2",Chromatin histone acetylation,none,931,266,,
85,256,JW-7-24-1,,LCK,"Other, kinases",none,977,266,,
86,286,KIN001-236,,Angiopoietin-1 receptor,Other,none,975,266,,
87,257,NPK76-II-72-1,,PLK3,Cell cycle,none,975,266,,
88,1166,QL-VIII-58,,"MTOR, ATR",Other,none,515,266,,
89,331,QL-X-138,,BTK,"Other, kinases",none,964,266,,
90,329,QL-XI-92,,DDR1,Other,none,977,266,,
91,235,QL-XII-47,,"BTK, BMX","Other, kinases",none,977,266,,
92,1203,QL-XII-61,,"BMX, BTK","Other, kinases",none,490,266,,
93,346,THZ-2-102-1,,CDK7,Cell cycle,none,957,266,,
94,344,THZ-2-49,,CDK9,Cell cycle,none,972,266,,
95,261,TL-1-85,,TAK,"Other, kinases",none,975,266,,
96,211,TL-2-105,,not defined,Unclassified,none,980,266,,
97,252,WZ3105,,"SRC, ROCK2, NTRK2, FLT3, IRAK1, others",Other,none,976,266,,
98,1158,XMD11-85h,,"BRSK2, FLT4, MARK4, PRKCD, RET, SRPK1",Other,none,513,266,,
99,330,XMD13-2,,RIPK1,Apoptosis regulation,none,976,266,,
100,253,XMD14-99,,"ALK, CDK7, LTK, others",Other,none,977,266,,
101,332,XMD15-27,,CAMK2,"Other, kinases",none,977,266,,
102,1161,ZG-10,,JNK1,JNK and p38 signaling,none,513,266,,
103,1261,rTRAIL,,TRAIL receptor agonist,Apoptosis regulation,none,949,266,,
104,263,FR-180204,"FR 180204, FR180204, ERK Inhibitor II","ERK1, ERK2",ERK MAPK signaling,11493598,975,266,11493598,Nc1[nH]nc2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12
105,166,FTI-277,,Farnesyl-transferase (FNTA),Other,3005532,937,266,3005532,COC(=O)C(CCSC)NC(=O)c1ccc(NCC(N)CS)cc1-c1ccccc1
106,306,Fedratinib,"TG101348, TG-101348, SAR302503, SAR-302503",JAK2,"Other, kinases",16722836,976,266,16722836,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
107,308,Foretinib,"GSK1363089, XL-880, EXEL-2880, GSK089","MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR",RTK signaling,42642645,972,266,42642645,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1
108,52,GNF-2,KIN001-013,BCR-ABL,ABL signaling,5311510,423,266,5311510,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1
109,226,GSK1070916,GSK-1070916,"AURKA, AURKC",Mitosis,46885626,950,266,46885626,CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1
110,202,GSK1904529A,"GSK-1904529A, GSK 1904529A","IGF1R, IR",IGFR signaling,25124816,928,266,25124816,CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1
111,127,GSK269962A,GSK 269962A,"ROCK1, ROCK2",Cytoskeleton,16095342,429,266,16095342,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21
112,1192,GSK269962A,GSK 269962A,"ROCK1, ROCK2",Cytoskeleton,16095342,958,266,16095342,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21
113,91,GSK319347A,"KIN001-135, IKK-3 inhibitor",IKK,Other,11626927,428,266,11626927,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC
114,230,GSK429286A,,"ROCK1, ROCK2",Cytoskeleton,11373846,980,266,11373846,CC1=C(C(=O)Nc2cc3cn[nH]c3cc2F)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1
115,177,GSK650394,"GSK-650394, GSK 650394","SGK2, SGK3",Other,25022668,920,266,25022668,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1
116,326,GSK690693,"GSK 690693, GSK-690693","AKT1, AKT2, AKT3",PI3K/MTOR signaling,16725726,975,266,16725726,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCCNC3)c21
117,193,GW-2580,"GX2580, CFMS receptor tyrosine kinase inhibitor",CSF1R,RTK signaling,11617559,977,266,11617559,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1
118,1023,GW441756,GW 441756,NTRK1,RTK signaling,9943465,879,266,9943465,Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21
119,87,GW843682X,GW843682X (AN-13),PLK1,Cell cycle,9826308,426,266,9826308,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC
120,1010,Gefitinib,"ZD-1839, Iressa",EGFR,EGFR signaling,123631,878,266,123631,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1
121,135,Gemcitabine,"Gemzar, LY-188011",Pyrimidine antimetabolite,DNA replication,60750,923,266,60750,Nc1ccn(C2OC(CO)C(O)C2(F)F)c(=O)n1
122,159,HG6-64-1,KIN001-206,BRAF,ERK MAPK signaling,53302361,933,266,53302361,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C=Cc4cnc5[nH]ccc5c4OC)c3)cc2C(F)(F)F)CC1
123,275,I-BET-762,GSK525762A,"BRD2, BRD3, BRD4",Chromatin other,46943432,972,266,46943432,CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21
124,1266,ICL1100013,,N-myristoyltransferase 1/2,Other,nan,945,266,,
125,1230,IOX2,"IOX-2, IOX 2, AK176060",EGLN1,Other,54685215,959,266,54685215,O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O
126,176,IPA-3,IPA 3,PAK1,Cytoskeleton,521106,927,266,521106,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12
127,238,Idelalisib,"CAL-101, Zydelig",PI3Kdelta,PI3K/MTOR signaling,11625818,979,266,11625818,CCC(Nc1ncnc2nc[nH]c12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1
128,34,Imatinib,"Gleevec, STI-571","ABL, KIT, PDGFR",RTK signaling,5291,435,266,5291,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
129,208,Ispinesib Mesylate,SB-715992,KSP,Mitosis,6450816,979,266,6450816,CS(=O)(=O)O.Cc1ccc(C(=O)N(CCCN)C(c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1
130,1043,JNK Inhibitor VIII,,JNK,JNK and p38 signaling,11624601,876,266,11624601,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N
131,157,JNK-9L,"KIN001-204, JNK inhibitor 9l","JNK2, JNK3",JNK and p38 signaling,25222038,937,266,25222038,Fc1cc(-c2ccnc(Nc3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1
132,163,JQ1,"JQ-1, (+)-JQ-1","BRD2, BRD3, BRD4, BRDT",Chromatin other,46907787,937,266,46907787,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2
133,1218,JQ1,"JQ-1, (+)-JQ-1","BRD2, BRD3, BRD4, BRDT",Chromatin other,46907787,944,266,46907787,Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=NC(CC(=O)OC(C)(C)C)c1nnc(C)n1-2
134,83,JW-7-52-1,,MTOR,PI3K/MTOR signaling,49836027,410,266,49836027,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1
135,287,KIN001-244,PDK1 inhibitor 7,PDK1 (PDPK1),"Other, kinases",56965967,974,266,56965967,O=C(NC(COc1ccc2[nH]c(=O)[nH]c2c1)c1ccccc1)c1cccn(Cc2ccc(F)c(F)c2)c1=O
136,290,KIN001-260,"Bayer IKKb inhibitor, ACHP",IKKB,Other,10451420,974,266,10451420,N#CC1=C(N)NC(=C2C(=O)C=CC=C2OCC2CC2)C=C1C1CCNCC1
137,291,KIN001-266,,MAP3K8,"Other, kinases",44143370,975,266,44143370,CCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1
138,345,KIN001-270,"CDK9 inhibitor, CDK9-IN-1",CDK9,Cell cycle,66577006,975,266,66577006,Cc1ccc(Nc2cc(-c3cccc(N4C(=O)c5ccccc5C4=O)c3)ncn2)cc1NS(C)(=O)=O
139,1030,KU-55933,KU55933,ATM,Genome integrity,5278396,877,266,5278396,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1
140,192,LFM-A13,DDE-28,BTK,"Other, kinases",54676905,927,266,54676905,CC(O)=C(C#N)C(=O)Nc1cc(Br)ccc1Br
141,119,Lapatinib,"Tykerb, Tyverb","ERBB2, EGFR",EGFR signaling,208908,421,266,208908,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1
142,1020,Lenalidomide,"CDC-501, CC-5013, Revlimid",CRBN,Protein stability and degradation,216326,882,266,216326,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
143,1024,Lestaurtinib,"CEP-701, SP-924, SPM-924, A-154475, KT-555","FLT3, JAK2, NTRK1, NTRK2, NTRK3","Other, kinases",126565,881,266,126565,CC12OC(CC1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
144,277,Linifanib,"ABT-869, ABT 869","VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT",RTK signaling,11485656,977,266,11485656,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1
145,185,Linsitinib,"OSI-906, ASP-7487",IGF1R,IGFR signaling,11640390,924,266,11640390,CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1
146,194,Luminespib,"AUY922, VER-52296,NVP-AUY922,  AUY",HSP90,Protein stability and degradation,10096043,918,266,10096043,CCNC(=O)C1=C(c2ccc(CN3CCOCC3)cc2)C(=C2C=C(C(C)C)C(O)=CC2=O)ON1
147,9,MG-132,"LLL cpd, MG 132, MG132","Proteasome, CAPN1",Protein stability and degradation,462382,426,266,462382,CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1
148,1053,MK-2206,"MK 2206, MK2206","AKT1, AKT2",PI3K/MTOR signaling,46930998,854,266,46930998,Cl.Cl.NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1
149,294,MPS-1-IN-1,,MPS1,Mitosis,25195352,973,266,25195352,COc1cc(N2CCC(O)CC2)ccc1Nc1cc(Nc2ccccc2S(=O)(=O)C(C)C)c2cc[nH]c2n1
150,292,Masitinib,"AB1010, Masivet","KIT, PDGFRA, PDGFRB","Other, kinases",10074640,976,266,10074640,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
151,1008,Methotrexate,"Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex",Antimetabolite,DNA replication,126941,881,266,126941,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1
152,136,Mitomycin-C,"Mytozytrex, NSC-26980, MMC, Mitosol, Mitozytrex",DNA crosslinker,DNA replication,5746,929,266,5746,COC12C(COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1CC1NC12
153,1029,Motesanib,"AMG-706, AMG 706, AMG706","VEGFR, RET, KIT, PDGFR",RTK signaling,11667893,877,266,11667893,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21
154,260,NG-25,NG25,"TAK1, MAP4K2","Other, kinases",53340664,974,266,53340664,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1
155,269,NSC-207895,"XI-006, NSC207895",MDM4,p53 pathway,42640,968,266,42640,CN1CCN(c2ccc([N+](=O)[O-])c3no[n+]([O-])c23)CC1
156,147,NSC-87877,NSC 87877,"SHP-1 (PTPN6), SHP-2 (PTPN11)",Other,5459322,933,266,5459322,O=C1C(=NNc2ccc3cc(S(=O)(=O)O)ccc3c2)C=C(S(=O)(=O)O)c2cccnc21
157,1038,NU7441,"KU-57788, NU-7432, NU-7741",DNAPK,Genome integrity,11327430,875,266,11327430,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12
158,295,NVP-BHG712,BHG712,EPHB4,Other,16747388,975,266,16747388,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc(-c2cccnc2)nc2c1cnn2C
159,35,NVP-TAE684,"NVP-TAE 684, TAE684, TAE-684",ALK,RTK signaling,16038120,433,266,16038120,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
160,1011,Navitoclax,"ABT-263, ABT263, ABT 263","BCL2, BCL-XL, BCL-W",Apoptosis regulation,24978538,878,266,24978538,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NC(CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1
161,1013,Nilotinib,"Tasigna, AMN 107",ABL,ABL signaling,644241,833,266,644241,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
162,1047,Nutlin-3a (-),,MDM2,p53 pathway,11433190,878,266,11433190,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1
163,299,OSI-027,A-1065-5,"MTORC1, MTORC2",PI3K/MTOR signaling,44224160,971,266,44224160,COc1cccc2c1=NC(=c1nc(C3CCC(C(=O)O)CC3)n3c1=C(N)N=CN3)C=2
164,298,OSI-930,OSI 930 OSI930,KIT,RTK signaling,9868037,976,266,9868037,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12
165,167,OSU-03012,"AR-12, OSU 03012, OSU03012, PDK1 inhibitor AR-12",PDK1 (PDPK1),"Other, kinases",10027278,927,266,10027278,NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1
166,182,Obatoclax Mesylate,"GX15-070MS, Obatoclax, GX15-070","BCL2, BCL-XL, BCL-W, MCL1",Apoptosis regulation,11404337,920,266,11404337,COc1cc(=C2C=c3ccccc3=N2)[nH]c1=Cc1[nH]c(C)cc1C
167,1017,Olaparib,"AZD2281, KU0059436,  Lynparza","PARP1, PARP2",Genome integrity,23725625,882,266,23725625,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
168,1495,Olaparib,"AZD2281, KU0059436,  Lynparza","PARP1, PARP2",Genome integrity,23725625,934,266,23725625,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
169,283,Omipalisib,"GSK2126458, GSK-2126458, EX-8678, GSK458","PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,25167777,977,266,25167777,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F
170,175,PAC-1,GTPL5238,"Procaspase-3, Procaspase-7",Apoptosis regulation,6753378,916,266,6753378,C=CCC1=CC=CC(=CNNC(=O)CN2CCN(Cc3ccccc3)CC2)C1=O
171,1060,PD0325901,"PD-0325901, PD 0325901","MEK1, MEK2",ERK MAPK signaling,9826528,870,266,9826528,O=C(NOCC(O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
172,1049,PD173074,"PD-173074, PD 173074","FGFR1, FGFR3",RTK signaling,1401,878,266,1401,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1
173,1129,PF-4708671,"PF 4708671, PF4708671",S6K1,PI3K/MTOR signaling,51371303,939,266,51371303,CCc1cncnc1N1CCN(Cc2nc3ccc(C(F)(F)F)cc3[nH]2)CC1
174,158,PF-562271,PF-00562271,"FAK, FAK2",Cytoskeleton,11713159,918,266,11713159,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O
175,1219,PFI-1,,BRD4,Chromatin other,71271629,961,266,71271629,COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2
176,1530,PFI-3,BDF00016096,"SMARCA2, SMARCA4, PB1",Other,78243717,874,266,78243717,O=C(C=CN1CC2CC1CN2c1ccccn1)c1ccccc1O
177,6,PHA-665752,"PHA665752, PHA 665752",MET,RTK signaling,10461815,434,266,10461815,Cc1[nH]c(C=C2C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCCC1CN1CCCC1
178,301,PHA-793887,"PHA793887, PHA 793887","CDK2, CDK7, CDK5",Cell cycle,46191454,977,266,46191454,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
179,302,PI-103,"PI-103, PI103, PI 103","PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2",PI3K/MTOR signaling,9884685,966,266,9884685,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1
180,303,PIK-93,"PIK 93, PIK93",PI3Kgamma,PI3K/MTOR signaling,6852167,975,266,6852167,CC(=O)Nc1nc(C)c(-c2ccc(Cl)c(S(=O)(=O)NCCO)c2)s1
181,1036,PLX-4720,"PLX4720, PLX 4720",BRAF,ERK MAPK signaling,24180719,877,266,24180719,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F
182,1371,PLX-4720,"PLX4720, PLX 4720",BRAF,ERK MAPK signaling,24180719,947,266,24180719,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F
183,11,Paclitaxel,"BMS-181339-01, Taxol, Onxol, Paxene, Praxel, Abraxane",Microtubule stabiliser,Mitosis,36314,426,266,36314,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C
184,1054,Palbociclib,"PD0332991, PD-0332991, PF-00080665-73","CDK4, CDK6",Cell cycle,5330286,854,266,5330286,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O
185,89,Parthenolide,,HDAC1,Chromatin histone acetylation,7251185,428,266,7251185,C=C1C(=O)OC2C1CCC(C)=CCCC1(C)OC21
186,199,Pazopanib,Votrient,"CSF1R, KIT,  PDGFRA, PDGFRB",RTK signaling,10113978,925,266,10113978,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
187,282,Pelitinib,"EKB-569, EKB 569",EGFR,EGFR signaling,6445562,976,266,6445562,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C
188,1529,Pevonedistat,"MLN4924, MLN 4924, MLN-4924",NAE,Other,16720766,722,266,16720766,NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O
189,196,Phenformin,DBI,Biguanide agent,Other,8249,966,266,8249,NC(N)=NC(N)=NCCc1ccccc1
190,1058,Pictilisib,"GDC-0941, GDC0941, RG-7621",PI3K (class 1),PI3K/MTOR signaling,17755052,870,266,17755052,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1
191,1527,Pictilisib,"GDC-0941, GDC0941, RG-7621",PI3K (class 1),PI3K/MTOR signaling,17755052,914,266,17755052,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1
192,1243,Piperlongumine,Piplartine,Induces reactive oxygen species,Other,637858,957,266,637858,COc1cc(C=CC(=O)N2CCC=CC2=O)cc(OC)c1OC
193,155,Ponatinib,"AP24534, AP-24534, KIN001-192, Iclusig","ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3",RTK signaling,24826799,937,266,24826799,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
194,71,Pyrimethamine,"Daraprim, Chloridine",Dihydrofolate reductase (DHFR),Other,4993,428,266,4993,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1
195,151,QS11,944328-88-5,ARFGAP1,Other,4263900,928,266,4263900,COc1cc2c(cc1OC)CN(C(C)C(=O)Nc1cc([N+](=O)[O-])ccc1Cl)CC2
196,254,Quizartinib,"AC220, AC 220, AC-220, Asp-2689",FLT3,RTK signaling,24889392,976,266,24889392,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
197,1052,RO-3306,,CDK1,Cell cycle,44450571,878,266,44450571,O=C1N=C(NCc2cccs2)SC1=Cc1ccc2ncccc2c1
198,3,Rapamycin,"AY-22989, Sirolimus, WY-090217, Torisel, Rapamune",MTORC1,PI3K/MTOR signaling,5384616,388,266,5384616,N#C[N]C(=Nc1ccccc1)NC#N
199,1014,Refametinib,"RDEA119, BAY-86-9766, BAY 869766","MEK1, MEK2",ERK MAPK signaling,44182295,869,266,44182295,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1
200,1526,Refametinib,"RDEA119, BAY-86-9766, BAY 869766","MEK1, MEK2",ERK MAPK signaling,44182295,905,266,44182295,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1
201,1175,Rucaparib,"PF-01367338, AG-014699, AG-14447, AG-14699","PARP1, PARP2",Genome integrity,9931953,953,266,9931953,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1.O=P(O)(O)O
202,206,Ruxolitinib,"INCB-18424, Ruxolitinib Phosphate, Jakafi","JAK1, JAK2","Other, kinases",25126798,979,266,25126798,N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1
203,41,S-Trityl-L-cysteine,"NSC 83265, Tritylcysteine",KIF11,Mitosis,76044,424,266,76044,NC(CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O
204,1025,SB216763,"SB-216763, SB 216763","GSK3A, GSK3B",WNT signaling,176158,778,266,176158,Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21
205,1194,SB505124,"SB 505124, SB505124","ALK4, ALK5",RTK signaling,9858940,958,266,9858940,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1
206,304,SB52334,"SB-52334, SB 52334",ALK5,RTK signaling,9967941,974,266,9967941,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3nccnc3c2)n1
207,1061,SB590885,SB-590885,BRAF,ERK MAPK signaling,11316960,858,266,11316960,CN(C)CCOc1ccc(-c2nc(=c3ccc4c(c3)CCC=4N=O)c(=C3C=CNC=C3)[nH]2)cc1
208,1264,SGC0946,,DOT1L,Chromatin histone methylation,56962337,938,266,56962337,CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2cc(Br)c3c(N)ncnc32)C(O)C1O
209,1039,SL0101,"SL-0101, SL 0101-1","RSK, AURKB, PIM1, PIM3",Other,10459196,863,266,10459196,CC(=O)OC1C(C)OC(Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C(O)C1OC(C)=O
210,1494,SN-38,"7-Ethyl-10-Hydroxy-Camptothecin, SN 38",TOP1,DNA replication,104842,989,266,104842,CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC
211,328,SNX-2112,SNX 2112,HSP90,Protein stability and degradation,24772860,967,266,24772860,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(NC4CCC(O)CC4)c3)c2C1
212,258,STF-62247,STF62247,Autophagy inducer,Other,704473,972,266,704473,Cc1cccc(Nc2nc(-c3ccncc3)cs2)c1
213,111,Salubrinal,EIF-2alpha Inhibitor,EIF2A,Other,5717801,423,266,5717801,O=C(C=Cc1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl
214,38,Saracatinib,"AZD0530, AZD-0530, AZ-10353926","ABL, SRC",RTK signaling,10302451,435,266,10302451,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1
215,110,Seliciclib,"Roscovitine, CYC-202, AL-39256","CDK2, CDK7, CDK9",Cell cycle,160355,421,266,160355,CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1
216,341,Selisistat,"EX-527, EX 527",SIRT1,Chromatin histone acetylation,5113032,971,266,5113032,NC(=O)C1CCCc2c1[nH]c1ccc(Cl)cc21
217,1062,Selumetinib,"AZD6244, AZD-6244, ARRY-886","MEK1, MEK2",ERK MAPK signaling,10127622,852,266,10127622,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21
218,1498,Selumetinib,"AZD6244, AZD-6244, ARRY-886","MEK1, MEK2",ERK MAPK signaling,10127622,950,266,10127622,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21
219,268,Sepantronium bromide,"YM155, YM-155, YM 155",BIRC5,Apoptosis regulation,11178236,942,266,11178236,COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Br-]
220,1133,Serdemetan,JNJ-26854165,MDM2,p53 pathway,11609586,950,266,11609586,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1
221,170,Shikonin,Anchusin,not defined,Other,5208,934,266,5208,CC(C)=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O
222,30,Sorafenib,"Nexavar, 284461-73-0, BAY 43-9006","PDGFR, KIT, VEGFR, RAF",RTK signaling,216239,430,266,216239,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1
223,5,Sunitinib,"Sutent, Sunitinib Malate, SU-11248","PDGFR, KIT, VEGFR, FLT3, RET, CSF1R",RTK signaling,5329102,425,266,5329102,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C
224,333,T0901317,"TO-901317, TO901317","LXR, FXR",Other,447912,969,266,447912,O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1
225,221,TAK-715,"KIN001-201, TAK 715","p38alpha, p38beta",JNK and p38 signaling,9952773,980,266,9952773,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1
226,94,TGX221,"TGX-221, Tgx 221",PI3Kbeta,PI3K/MTOR signaling,9907093,426,266,9907093,Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1
227,305,TPCA-1,,IKK2,"Other, kinases",9903786,975,266,9903786,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O
228,1149,TW 37,"TW37, TW-37","BCL2, BCL-XL, MCL1",Apoptosis regulation,11455910,952,266,11455910,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O
229,1259,Talazoparib,"BMN-673, BMN 973","PARP1, PARP2",Genome integrity,44819241,944,266,44819241,Cn1ncnc1C1C2=c3c(cc(F)cc3=NC1c1ccc(F)cc1)C(=O)NN2
230,1199,Tamoxifen,"Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar",ESR1,Hormone-related,2733526,958,266,2733526,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
231,1026,Tanespimycin,"17-AAG, BMS-722782",HSP90,Protein stability and degradation,6505803,879,266,6505803,C=CCNC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O
232,1375,Temozolomide,"Temodar, Temodal, M-39831, SCH 52365",DNA alkylating agent,DNA replication,5394,938,266,5394,Cn1nnc2c(C(N)=O)ncn2c1=O
233,1016,Temsirolimus,"CCI-779, Torisel",MTOR,PI3K/MTOR signaling,6918289,868,266,6918289,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OC(=O)C(C)(CO)CO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C
234,180,Thapsigargin,Octanoic acid,SERCA,Other,446378,911,266,446378,CC=C(C)C(=O)OC1C(C)=C2C(C1OC(=O)CCCCCCC)C(C)(OC(C)=O)CC(OC(=O)CCC)C1(O)C2OC(=O)C1(C)O
235,204,Tipifarnib,Zarnestra,Farnesyl-transferase (FNTA),Other,159324,925,266,159324,Cn1cncc1C(N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C
236,312,Tivozanib,"AV-951, AV 951, KRN-951, KIL8951, ASP-4130","VEGFR1, VEGFR2, VEGFR3",RTK signaling,9911830,975,266,9911830,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
237,32,Tozasertib,"MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68","AURKA, AURKB, AURKC, others",Mitosis,5494449,420,266,5494449,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1
238,1372,Trametinib,"GSK1120212, Mekinist","MEK1, MEK2",ERK MAPK signaling,11707110,925,266,11707110,CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1
239,1009,Tretinoin,"ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita",Retinoic acid,Other,444795,873,266,444795,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O
240,265,Tubastatin A,,"HDAC1, HDAC6, HDAC8",Chromatin histone acetylation,53394750,971,266,53394750,CN1CCc2c(c3ccccc3n2Cc2ccc(C(=O)NO)cc2)C1.OOC#CF
241,245,UNC0638,"UNC-0638, UNC 0683",G9a and GLP methyltransferases,Chromatin histone methylation,46224516,969,266,46224516,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
242,1236,UNC0638,"UNC-0638, UNC 0683",G9a and GLP methyltransferases,Chromatin histone methylation,46224516,961,266,46224516,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
243,1262,UNC1215,UNC-1215,L3MBTL3,Chromatin other,57339144,939,266,57339144,O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1
244,271,VNLG/124,HDAC inhibitor XV,"HDAC,RAR",Chromatin histone acetylation,24894414,971,266,24894414,CCCC(=O)OCc1ccc(OC(=O)C=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)cc1
245,262,VX-11e,"VX11e, VX11e",ERK2,ERK MAPK signaling,11634725,974,266,11634725,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)NC(CO)c2cccc(Cl)c2)c1
246,1028,VX-702,"VX702, VX 702",p38,JNK and p38 signaling,10341154,879,266,10341154,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F
247,1018,Veliparib,"ABT-888, ABT888, ABT 888","PARP1, PARP2",Genome integrity,11960529,882,266,11960529,CC1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1
248,1004,Vinblastine,Velban,Microtubule destabiliser,Mitosis,6710780,882,266,6710780,CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3cc4c(cc3OC)N(C)C3C(O)(C(=O)OC)C(OC(C)=O)C5(CC)C=CCN6CCC43C65)C2)C1
249,140,Vinorelbine,"vinorelbine tartrate, Navelbine, Exelbine",Microtubule destabiliser,Mitosis,5311497,938,266,5311497,CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)C(C(=O)OC)(c1cc3c(cc1OC)N(C)C1C(O)(C(=O)OC)C(OC(C)=O)C4(CC)C=CCN5CCC31C54)C2
250,1033,Vismodegib,"GDC0449, Erivedge",SMO,Other,24776445,882,266,24776445,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1
251,1012,Vorinostat,"Zolinza, SAHA, suberanilohydroxamic acid, suberoylanilide hydroxamic acid, MK-0683","HDAC inhibitor Class I, IIa, IIb, IV",Chromatin histone acetylation,5311,883,266,5311,O=C(CCCCCCC(=O)Nc1ccccc1)NO
252,56,WH-4-023,KIN001-112,"SRC, LCK","Other, kinases",11844351,423,266,11844351,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1
253,288,WHI-P97,"AC1L1GQE, KIN001-055",JAK3,"Other, kinases",3796,975,266,3796,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC
254,59,WZ-1-84,KIN001-123,BMX,"Other, kinases",49821040,425,266,49821040,C=CC(=O)N1CCCC(Nc2nc(Nc3ccc(N(C)C(=O)CC)cc3)nc3nc[nH]c23)C1
255,1046,Wee1 Inhibitor,"681640, Wee1 Inhibitor","WEE1, CHEK1",Cell cycle,10384072,787,266,10384072,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21
256,1268,XAV939,"NVP-XAV939, XAV-939, XAV 939","TNKS1, TNKS2",WNT signaling,2726824,947,266,2726824,O=c1nc(-c2ccc(C(F)(F)F)cc2)[nH]c2c1CSCC2
257,106,XMD8-85,ERK5-IN-1,"ERK5, BET",Other,46844147,422,266,46844147,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
258,1164,XMD8-92,XMD 8-92,MAPK7,"Other, kinases",46843772,514,266,46843772,CCOc1cc(N2CCC(O)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
259,309,Y-39983,,ROCK,Cytoskeleton,9810884,975,266,9810884,CC(N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1
260,1239,YK-4-279,YK 4-279,RNA helicase A,Other,44632017,816,266,44632017,COc1ccc(C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1
261,310,YM201636,"YM-201636, YM 201636",PIKFYVE,Other,9956222,975,266,9956222,Nc1ccc(C(=O)Nc2cccc(-c3nc(N4CCOCC4)c4oc5ncccc5c4n3)c2)cn1
262,45,Z-LLNle-CHO,"Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1",gamma-secretase,Other,16760646,425,266,16760646,CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1
263,1050,ZM447439,"ZM-447439, ZM 447439","AURKA, AURKB",Mitosis,9914412,827,266,9914412,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1
264,223,ZSTK474,"KIN001-167, ZSTK-474, ZSTK 474",PI3K (class 1),PI3K/MTOR signaling,11647372,979,266,11647372,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1
265,266,Zibotentan,"ZD4054, ZD-4054",Endothelin-1 receptor (EDNRA),Other,9910224,974,266,9910224,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1
